Otsuka Sues Zydus To Block Generic Abilify

By Elaine Meyer ( June 10, 2010, 4:36 PM EDT) -- Indian drugmaker Cadila Healthcare Ltd. and its U. S. subsidiary Zydus Pharmaceuticals USA Inc. have become the latest targets of Otsuka Pharmaceutical Co. Ltd. 's legal campaign to prevent the launch of a generic version of the company's schizophrenia drug Abilify. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login